K'Lynne Johnson

Ms Johnson is a Non-executive Director of US based companies JM Huber Corporation (2020 to present), DMC Biotechnologies, Inc (March 2025 to present) and FMC Corporation (2013 to present). She is also Chair of Trinseo SA (2017 to present). The latter two companies are listed on the NYSE. Ms Johnson has had a global career with knowledge of the US market and has spent time in Asia. Ms Johnson was an executive in the chemicals industry for over 28 years and has worked in early stage sustainability-driven ventures as well as in more mature businesses. Ms Johnson is the former Chair of Elevance Renewable Sciences Inc (2015 to 2016) following eight years as President and founding CEO (2007 to 2015). Prior to joining Elevance, Ms Johnson spent over fifteen years in the oil and petrochemical industry with Amoco Corporation (1991 to 1999) and BP Chemicals (1999 to 2004), joining BP after its merger with Amoco in 1998. During this time, she held both operational and functional roles, culminating in her role as Senior Vice President of Global Derivatives with BP's Innovene business (2004 to 2005) (which was sold to the Ineos group in 2005). In addition, she was the co-founder and owner of BeauLily LLC (2006 to 2014), a therapeutic hand products company and a Non-executive Director of Sylvatex Inc (2016 to March 2025), an advanced materials technology company. She Johnson is based in North America. Ms Johnson is Chair of the People, Culture Committee and a member of the Safety and Sustainability Committee.